Last reviewed · How we verify

NCT05365815: MGMC

Melanated Group Midwifery Care (MGMC)

Recruiting now NA Last updated 3 July 2024
What this trial tests

NA trial testing Melanated Group Midwifery Care in Pregnancy Complications in 432 participants. Currently enrolling.

Timeline
8 June 2022
Primary endpoint
15 May 2026
1 February 2027

Quick facts

Lead sponsorUniversity of Illinois at Chicago
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposehealth services research
Enrollment432
Start date8 June 2022
Primary completion15 May 2026
Estimated completion1 February 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Illinois at Chicago

Who can join

Adults 15 to 49, female only, with Pregnancy Complications or Maternal Care Patterns. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is being conducted to determine if a multi-level intervention for delivering maternity care can improve patient trust and engagement among Black birthing people.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pregnancy Complications

Currently open trials in the same condition.

Other University of Illinois at Chicago trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05365815.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing